3 Insulin Therapy in Diabetes.2017pptx - Family Medicine · “Insulin Therapy in Type 2 Diabetes...
Transcript of 3 Insulin Therapy in Diabetes.2017pptx - Family Medicine · “Insulin Therapy in Type 2 Diabetes...
7/10/17
1
InsulinTherapyinDiabetesSoManyChoices…
DianaMcNeillMD,FACPProfessorofMedicine
DukeUniversityMedicalCenter
Disclosures
• Mytonomy-consultant• Quantia –webinars• Acknowledgements:
– Dr.SueKirkman-UNC- ChapelHill– Dr.SteveEdelman-UC-SanDiego– JanNicolleratDiabetes EducatorEmeritusDuke
7/10/17
2
• 45yearoldmalewithType2diabetestimes5years
• MetforminandGlipizide• HgbA1C9.5(decreasedfrom11%atdiagnosis)
• Feelspoorly-• Hisbossaskedhim-”whyareyousolethargic?”
Shouldhestartinsulin?
7/10/17
3
Basal
• Backgroundinsulin
Bolus
• Mealinsulin• Correction(Notslidingscale)
7/10/17
4
InsulinPreparationsModifiedhumaninsulins Regular,NPH
Insulinanalogs RapidActing:Aspart,Glulisine,LisproLongActing:Glargine,Detemir,Degludec
Premixedinsulins HumanN/R:70/30,50/50(Proportions) “N”/Analog:70/30,75/25
Degludec/Aspart:70/30
ConcentrationsotherthanU-100 U-500RegularDegludec U-200Lispro U-200GlargineU-300
Basalinsulin+GLP1agonists IDegLira,LixiLan
BiosimilarInsulin BasaGlar (glargine)
Insulinotherthanbyshots InhaledinsulinDisposableinsulindeliverydevice
Kirkman,ACPPrecourse,2017
Whatdoesitallmean?
• U-100• U-200• U-300• U-500
7/10/17
5
Aunitisaunit
WhichBasaltoUse?
• NPHmuchcheaper(uninsured/doughnutholepatient);cautionregardinghypoglycemia
• Ifhypoglycemiaaconcern:Basalanalog– Biosimilarglarginemodestlylesscostly(discusslater)
• Ifhypoglycemiaonglargineordetemir– Considerdegludec orglargineU-300
Kirkman,ACP2017
7/10/17
6
Patientscanadjusttheirinsulin
• Mathliteracy• Checkbloodglucose• Clearglycemicgoals• Avoidhypoglycemia
CostisafactorInsulin Cost Delivery
NPH(Novolin) $24.00 10mlof100units/ml
Lantus $266.78 5pens/3ml
Basalgar $333.32 5pens/3ml
Toujeo $275.28 3pens/1.5ml
Tresiba $464.38 5pens/3ml
PricesfromGoodRx atWalmart5/2017
7/10/17
7
Factorsthataffectinsulinabsorption
Exercise Strenuous use of injected limb within one hour
Massage of area Do not rub site vigorously
Temperature Heat increases, cold decreases
Site of Injection Abdomen>arms>thigh (R & N only)
Lipohypertrophy Delays absorption
Large doses (>80 units)
Delay onset and duration
Adapted from www.endotext.org, 2004
PatternAdjustmentsinInsulinTherapy
• KnowTargetBloodGlucoses• Gatherdata• Lookforpatterns• Assessinfluencingfactors• Takeaction
7/10/17
8
DiabetesManagementDosingInfoforSQInsulin:KEYisWEIGHT-
BASEDTotalDailyDose
Type1– start0.3-0.5units/kg/dayOftenquitesensitive;startonlowend
Type2– start0.3-0.7units/kg/dayNewtoinsulin:startonlowend
Somepatientsmayrequire>1unit/kg/day
Lien LF, Cox ME, Feinglos MN, Corsino L. (eds.) Glycemic Control in the Hospitalized Patient, 1st Edition. Springer, 2010
EXAMPLE: 100 kilogram patient X 0.3 units/kg/day = 30 units /day = Total Daily Dose
TruthorMyth?Addingasingleinjectionofinsulinatbedtimetoyouroralmedicationscan
makealargeimprovementinyourbloodsugarlevels?
Absolutely TrueJanNicolleratANP,CDE
7/10/17
9
CombinationTherapy
• 1injectionperday• Convenience(usuallygivenatnight)• Slow,safe,andsimpletitration• Noneorlimitedweightgain• Effectiveimprovementinglucosecontrol
6-37
DiabetesManagement
DistributionoftheTotalDailyDoseBasicStartingRegimens:(Type2…)(Oralplus)BasalInsulinTherapy(1-injection)
PremixedInsulinTherapy(2-injections)
Intensification:(Type1andType2)MostIntensive:Basal-BolusInsulinTherapy(4-shots)
Inbetween:StepwiseAdditionofBolusInsulintoBasalInsulin
Leahy JL. “Insulin Therapy in Type 2 Diabetes Mellitus” Endocrinol Metab Clin North Am01-MAR-2012; 41(1): 119-44
7/10/17
10
A59year-oldeducatedbusinessmaniscurrentlyonmaximumdosesof3oralagents:Metformin1000mgBID,Glipizide20mgBIDandPioglitazone45mgQD
Refusedtostartinsulinforyears,butdidtry10unitsofglargine atbedtime.It“didnotwork”andhestoppeditweeksago.A1c>8.8%forthepast3years.CurrentHGMresultsbelow.
JanNicolleratANP,CDE
B L D HS
Mon 227 --- --- 195
Tues 241 --- 179 ---Wed 199 --- --- ---Thurs 265 --- 168 ---
Case Presentation
JanNicolleratANP,CDE
7/10/17
11
Why did this person with diabetes have such a hard time?
A.Patient inertia: He was afraid to start insulin
B.PCP inertia: The physician waited too long to discuss insulin
C.The dose of insulin was not increased appropriately